Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,921 | 50,728 | 76,955 | 88,227 | 105,758 |
| Marketable Securities | 307,737 | 358,704 | 379,872 | 416,750 | 440,629 |
| Receivables | 2,204 | 1,335 | 2,995 | 5,981 | 11,532 |
| Inventories | 15,130 | 20,689 | 20,235 | 19,202 | 19,057 |
| Other current assets | 9,033 | 9,602 | 11,009 | 15,808 | 22,507 |
| TOTAL | $399,025 | $441,058 | $491,066 | $545,968 | $599,483 |
| Non-Current Assets | |||||
| PPE Net | 19,949 | 22,554 | 27,084 | 32,451 | 36,803 |
| Intangibles | 0 | 0 | 0 | 76,501 | 76,501 |
| Other Non-Current Assets | 23,270 | 30,667 | 43,593 | 55,680 | 68,219 |
| TOTAL | $43,219 | $53,221 | $70,677 | $164,632 | $181,523 |
| Total Assets | $442,244 | $494,279 | $561,743 | $710,600 | $781,006 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,288 | 2,619 | 3,696 | 12,980 | 5,329 |
| Accrued Expenses | 29,729 | 29,142 | 37,410 | 36,557 | 44,853 |
| TOTAL | $52,112 | $50,694 | $59,879 | $68,204 | $83,989 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 230,764 | 246,627 | 260,999 | 275,758 | 284,794 |
| TOTAL | $230,764 | $246,627 | $260,999 | $275,758 | $284,794 |
| Total Liabilities | $282,876 | $297,321 | $320,878 | $343,962 | $368,783 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,724 | 12,681 | 12,622 | 12,622 | 12,537 |
| Common Shares | 19 | 19 | 19 | 19 | 19 |
| Retained earnings | -3,435,170 | -3,389,333 | -3,338,211 | -3,201,193 | -3,141,505 |
| Other shareholders' equity | -6,352 | -6,450 | -5,681 | -6,907 | -8,169 |
| TOTAL | $159,368 | $196,958 | $240,865 | $366,638 | $412,223 |
| Total Liabilities And Equity | $442,244 | $494,279 | $561,743 | $710,600 | $781,006 |